Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-01-15
1999-12-14
Travers, Russell
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549512, 549544, A01N 4320, C07D30300, C07D30306
Patent
active
060018712
ABSTRACT:
A method for inhibiting the growth of lentiviruses and Herpetoviridae viruses, including HIV-1 and HSV-1, -2, respectively, in subjects, comprising administering to a subject in need of antiviral therapy a pharmaceutical composition comprising a therapeutically effective amount of a compound of the formula ##STR1## where: R is
REFERENCES:
T. Mosmann; (1983) "Rapid Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytotoxicity Assays" 65 Journal of Immunological Methods, 55-63.
Fahad A. Alrabiah and Stephen L. Sacks; (1996) "New Antiherpesvirus Agents Their Targets and Therapeutic Potential" Jul. 52 (1) Drugs 17-32.
Birgit Skoldenburg; (1996) "Herpes Simplex Encephalitis" 100 Scand J. Infect Dis. Suppl 8-13.
G.B. Elion; (1993) "Acyclovir: Discovery, Mechanism of Action, and Selectivity"1 Journal of Medical Virology Supplement 2-6.
Balkwill, F.R.; (1989) "Interferons" 1 Lancet 1060-1063.
Gadler, H.; (1983) "Nucleic Acid Hybridization for Measurement of Antiviral Compounds on Human Cytomegalvirus DNA Replication" 24 Antimicrob. Agents Chemother 370-374.
Hartman A.F.; (1997) "Prim Care" 24(3) 531-559.
Hayashi et al.; (1996) "Characterization of Antiviral Activity of Sesquitrepene, Triptofordin" 37 J. Antimicrob. Chemotherap. 759-768.
Japour et al.; (1993) "Antimicro Agents Chemotherapy" 37:1095-1101.
McDonald et al.; (1997) 157(9) "Arch. Intern. Med." 951-959.
Okogun et al.; (1982) "Roseanolone: A New Diterpene from Hypoestes Rosea" 37c Z. Naturforsc. 558-561.
Antona J. Wagstaff, et al.; (1994) "Aciclovir: A Reappraisal of its Antiviral Activity, Pharmacokinetic Properties and Therapeutic Efficacy" 47 (1) Drugs 153-204.
Balfour, H.H. Jr., 1999, "Drug Therapy: Antiviral Drugs," vol. 340 The New England Journal of Medicine, No. 16, pp. 1255-1268, Massachusetts Medical Society.
Ojo-Amaize Emmanuel A.
Okogun Joseph I.
Immune Modulation, Inc.
Travers Russell
LandOfFree
Hypoestoxides, derivatives and agonists thereof for use as antiv does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hypoestoxides, derivatives and agonists thereof for use as antiv, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hypoestoxides, derivatives and agonists thereof for use as antiv will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-863907